Advertisement
Screener

GALECTIN THERAPEUTICS INC. (GALT) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

GALECTIN THERAPEUTICS INC. Stock-Based Compensation

GALECTIN THERAPEUTICS INC. (GALT) reported Stock-Based Compensation of $1.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-14

  • GALECTIN THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $963.00K, a 92.60% increase year-over-year.
  • GALECTIN THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $686.00K, a 46.58% increase year-over-year.
  • GALECTIN THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $195.00K, a 66.95% decline year-over-year.
  • GALECTIN THERAPEUTICS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $496.00K, a 3.69% decline year-over-year.
  • GALECTIN THERAPEUTICS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $1.66M, a 32.20% decline from fiscal 2024.
  • GALECTIN THERAPEUTICS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $2.45M, a 8.23% increase from fiscal 2023.
  • GALECTIN THERAPEUTICS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $2.26M, a 21.14% decline from fiscal 2022.
  • GALECTIN THERAPEUTICS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $2.87M, a 38.10% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 132 monthShare-based Payment Arrangement, Noncash Expense 135 monthShare-based Payment Arrangement, Noncash Expense 138 monthShare-based Payment Arrangement, Noncash Expense 141 monthShare-based Payment Arrangement, Noncash Expense 144 monthShare-based Payment Arrangement, Noncash Expense 147 monthShare-based Payment Arrangement, Noncash Expense 150 monthShare-based Payment Arrangement, Noncash Expense 153 monthShare-based Payment Arrangement, Noncash Expense 156 monthShare-based Payment Arrangement, Noncash Expense 159 monthShare-based Payment Arrangement, Noncash Expense 162 monthShare-based Payment Arrangement, Noncash Expense 165 month
2026-06-30$963.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$1.65M
10-Q · filed 2026-08-14
$1.84M
derived: sum of 3 quarters · filed 2026-08-14
$2.34M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$686.00K
10-Q · filed 2026-05-15
$881.00K
derived: sum of 2 quarters · filed 2026-05-15
$1.38M
derived: sum of 3 quarters · filed 2026-05-15
$1.88M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$195.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$691.00K
derived: sum of 2 quarters · filed 2026-03-31
$1.19M
derived: sum of 3 quarters · filed 2026-08-14
$1.66M
10-K · filed 2026-03-31
2025-09-30$496.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$996.00K
derived: sum of 2 quarters · filed 2026-08-14
$1.46M
10-Q · filed 2025-11-14
$2.05M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$500.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$968.00K
10-Q · filed 2026-08-14
$1.56M
derived: sum of 3 quarters · filed 2026-08-14
$2.07M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$468.00K
10-Q · filed 2026-05-15
$1.06M
derived: sum of 2 quarters · filed 2026-05-15
$1.57M
derived: sum of 3 quarters · filed 2026-05-15
$2.31M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$590.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$1.10M
derived: sum of 2 quarters · filed 2026-03-31
$1.84M
derived: sum of 3 quarters · filed 2026-03-31
$2.45M
10-K · filed 2026-03-31
2024-09-30$515.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$1.25M
derived: sum of 2 quarters · filed 2025-11-14
$1.86M
10-Q · filed 2025-11-14
$2.35M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$738.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$1.34M
10-Q · filed 2025-08-14
$1.84M
derived: sum of 3 quarters · filed 2025-08-14
$2.42M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$604.00K
10-Q · filed 2025-05-15
$1.10M
derived: sum of 2 quarters · filed 2025-05-15
$1.69M
derived: sum of 3 quarters · filed 2025-05-15
$2.20M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$497.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$1.08M
derived: sum of 2 quarters · filed 2025-03-31
$1.60M
derived: sum of 3 quarters · filed 2025-03-31
$2.26M
10-K · filed 2025-03-31
2023-09-30$586.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$1.10M
derived: sum of 2 quarters · filed 2024-11-14
$1.76M
10-Q · filed 2024-11-14
$2.44M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$516.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$1.18M
10-Q · filed 2024-08-13
$1.86M
derived: sum of 3 quarters · filed 2024-08-13
$2.54M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$662.00K
10-Q · filed 2024-05-15
$1.34M
derived: sum of 2 quarters · filed 2024-05-15
$2.02M
derived: sum of 3 quarters · filed 2024-05-15
$2.67M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$681.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$1.36M
derived: sum of 2 quarters · filed 2024-03-29
$2.01M
derived: sum of 3 quarters · filed 2024-03-29
$2.87M
10-K · filed 2024-03-29
2022-09-30$681.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$1.33M
derived: sum of 2 quarters · filed 2023-11-13
$2.19M
10-Q · filed 2023-11-13
$2.84M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$647.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$1.50M
10-Q · filed 2023-08-14
$2.16M
derived: sum of 3 quarters · filed 2023-08-14
$2.75M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$858.00K
10-Q · filed 2023-05-15
$1.51M
derived: sum of 2 quarters · filed 2023-05-15
$2.10M
derived: sum of 3 quarters · filed 2023-05-15
$2.68M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$654.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$1.24M
derived: sum of 2 quarters · filed 2023-03-30
$1.82M
derived: sum of 3 quarters · filed 2023-03-30
$2.08M
10-K · filed 2023-03-30
2021-09-30$587.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$1.17M
derived: sum of 2 quarters · filed 2022-11-14
$1.42M
10-Q · filed 2022-11-14
$1.99M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$581.00K
10-Q · filed 2021-08-16
$835.00K
10-Q · filed 2022-08-15
$1.40M
derived: sum of 3 quarters · filed 2022-05-16
$1.81M
derived: sum of 4 quarters · filed 2022-05-16
2021-03-31$254.00K
10-Q · filed 2022-05-16
$821.00K
derived: sum of 2 quarters · filed 2022-05-16
$1.23M
derived: sum of 3 quarters · filed 2022-05-16
$1.62M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$567.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$975.00K
derived: sum of 2 quarters · filed 2022-03-31
$1.37M
derived: sum of 3 quarters · filed 2022-03-31
$1.80M
10-K · filed 2022-03-31
2020-09-30$408.00K
10-Q · filed 2020-11-09
$802.00K
derived: sum of 2 quarters · filed 2021-08-16
$1.23M
10-Q · filed 2021-11-15
$1.65M
derived: sum of 4 quarters · filed 2021-08-16
2020-06-30$394.00K
10-Q · filed 2021-08-16
$824.00K
10-Q · filed 2021-08-16
$1.24M
derived: sum of 3 quarters · filed 2021-08-16
$1.65M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$430.00K
10-Q · filed 2021-05-17
$844.00K
derived: sum of 2 quarters · filed 2021-05-17
$1.26M
derived: sum of 3 quarters · filed 2021-05-17
$1.70M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$414.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
$828.00K
derived: sum of 2 quarters · filed 2021-03-31
$1.27M
derived: sum of 3 quarters · filed 2021-03-31
$1.68M
10-K · filed 2021-03-31
2019-09-30$414.00K
10-Q · filed 2020-11-09
$857.00K
derived: sum of 2 quarters · filed 2020-11-09
$1.27M
10-Q · filed 2020-11-09
$2.42M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$443.00K
10-Q · filed 2020-08-10
$855.00K
10-Q · filed 2020-08-10
$2.01M
derived: sum of 3 quarters · filed 2020-08-10
$2.67M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$412.00K
10-Q · filed 2020-05-11
$1.56M
derived: sum of 2 quarters · filed 2020-05-11
$2.23M
derived: sum of 3 quarters · filed 2020-05-11
$3.67M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$1.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$1.81M
derived: sum of 2 quarters · filed 2020-03-16
$3.26M
derived: sum of 3 quarters · filed 2020-03-16
$4.45M
10-K · filed 2020-03-16
2018-09-30$663.00K
10-Q · filed 2019-11-12
$2.11M
derived: sum of 2 quarters · filed 2019-11-12
$3.29M
10-Q · filed 2019-11-12
$3.56M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$1.44M
10-Q · filed 2019-08-09
$2.63M
10-Q · filed 2019-08-09
$2.90M
derived: sum of 3 quarters · filed 2019-08-09
$3.13M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$1.19M
10-Q · filed 2019-05-10
$1.46M
derived: sum of 2 quarters · filed 2019-05-10
$1.69M
derived: sum of 3 quarters · filed 2019-05-10
$1.96M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$272.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
$502.00K
derived: sum of 2 quarters · filed 2019-03-06
$771.00K
derived: sum of 3 quarters · filed 2019-03-06
$1.10M
10-K · filed 2019-03-06
2017-09-30$230.00K
10-Q · filed 2018-11-13
$499.00K
derived: sum of 2 quarters · filed 2018-11-13
$829.00K
10-Q · filed 2018-11-13
$1.31M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$269.00K
10-Q · filed 2018-08-14
$599.00K
10-Q · filed 2018-08-14
$1.08M
derived: sum of 3 quarters · filed 2018-08-14
$1.45M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$330.00K
10-Q · filed 2018-05-11
$808.00K
derived: sum of 2 quarters · filed 2018-05-11
$1.18M
derived: sum of 3 quarters · filed 2018-05-11
$1.59M
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31$478.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
$854.00K
derived: sum of 2 quarters · filed 2018-03-29
$1.26M
derived: sum of 3 quarters · filed 2018-03-29
$2.48M
10-K · filed 2018-03-29
2016-09-30$376.00K
10-Q · filed 2017-11-07
$778.00K
derived: sum of 2 quarters · filed 2017-11-07
$2.00M
10-Q · filed 2017-11-07
$2.87M
derived: sum of 4 quarters · filed 2017-11-07
2016-06-30$402.00K
10-Q · filed 2017-08-14
$1.63M
10-Q · filed 2017-08-14
$2.50M
derived: sum of 3 quarters · filed 2017-08-14
$3.29M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$1.22M
10-Q · filed 2017-05-15
$2.10M
derived: sum of 2 quarters · filed 2017-05-15
$2.89M
derived: sum of 3 quarters · filed 2017-05-15
$3.69M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$873.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28
$1.67M
derived: sum of 2 quarters · filed 2017-03-28
$2.47M
derived: sum of 3 quarters · filed 2017-03-28
$3.40M
10-K · filed 2017-03-28
2015-09-30$793.00K
10-Q · filed 2016-11-08
$1.59M
derived: sum of 2 quarters · filed 2016-11-08
$2.53M
10-Q · filed 2016-11-08
$3.33M
derived: sum of 4 quarters · filed 2016-11-08
2015-06-30$800.00K
10-Q · filed 2016-08-09
$1.73M
10-Q · filed 2016-08-09
$2.53M
derived: sum of 3 quarters · filed 2016-08-09
$3.41M
derived: sum of 4 quarters · filed 2016-08-09
2015-03-31$935.00K
10-Q · filed 2016-05-10
$1.73M
derived: sum of 2 quarters · filed 2016-05-10
$2.61M
derived: sum of 3 quarters · filed 2016-05-10
$3.36M
derived: sum of 4 quarters · filed 2016-05-10
2014-12-31$799.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$1.68M
derived: sum of 2 quarters · filed 2016-03-15
$2.42M
derived: sum of 3 quarters · filed 2016-03-15
$4.07M
10-K · filed 2016-03-15
2014-09-30$877.00K
10-Q · filed 2015-11-09
$1.62M
derived: sum of 2 quarters · filed 2015-11-09
$3.27M
10-Q · filed 2015-11-09
$3.78M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$745.00K
10-Q · filed 2015-08-10
$2.39M
10-Q · filed 2015-08-10
$2.91M
derived: sum of 3 quarters · filed 2016-03-15
$4.71M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$1.65M
10-Q · filed 2015-05-11
$2.16M
derived: sum of 2 quarters · filed 2016-03-15
$3.97M
derived: sum of 3 quarters · filed 2016-03-15
$4.58M
derived: sum of 4 quarters · filed 2016-03-15
$17.81M
10-Q · filed 2014-05-13
2013-12-31$513.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$2.32M
derived: sum of 2 quarters · filed 2016-03-15
$2.94M
derived: sum of 3 quarters · filed 2016-03-15
$3.79M
10-K · filed 2016-03-15
$16.16M
10-K · filed 2014-03-21
2013-09-30$1.81M
10-Q · filed 2014-11-10
$2.42M
derived: sum of 2 quarters · filed 2014-11-10
$3.28M
10-Q · filed 2014-11-10
$3.90M
derived: sum of 4 quarters · filed 2015-03-18
$15.65M
10-Q · filed 2013-11-12
2013-06-30$615.00K
10-Q · filed 2013-08-14
$1.47M
10-Q · filed 2014-08-07
$2.09M
derived: sum of 3 quarters · filed 2015-03-18
$2.91M
derived: sum of 4 quarters · filed 2015-03-18
$13.84M
10-Q · filed 2013-08-14
2013-03-31$852.00K
10-Q · filed 2014-05-13
$1.47M
derived: sum of 2 quarters · filed 2015-03-18
$2.29M
derived: sum of 3 quarters · filed 2015-03-18
$3.17M
derived: sum of 4 quarters · filed 2015-03-18
$13.23M
10-Q · filed 2013-05-10
2012-12-31$622.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18
$1.44M
derived: sum of 2 quarters · filed 2015-03-18
$2.32M
derived: sum of 3 quarters · filed 2015-03-18
$2.79M
10-K · filed 2015-03-18
$12.37M
10-K · filed 2013-03-29
2012-09-30$819.00K
10-Q · filed 2013-11-12
$1.70M
derived: sum of 2 quarters · filed 2013-11-12
$2.17M
10-Q · filed 2013-11-12
$2.73M
derived: sum of 4 quarters · filed 2013-11-12
$11.75M
10-Q · filed 2012-11-09
2012-06-30$879.00K
10-Q · filed 2013-08-14
$1.35M
10-Q · filed 2013-08-14
$1.91M
derived: sum of 3 quarters · filed 2013-08-14
$2.56M
derived: sum of 4 quarters · filed 2013-08-14
$10.93M
10-Q · filed 2012-08-10
2012-03-31$473.00K
10-Q · filed 2013-05-10
$1.03M
derived: sum of 2 quarters · filed 2013-05-10
$1.68M
derived: sum of 3 quarters · filed 2013-05-10
$3.01M
derived: sum of 4 quarters · filed 2013-05-10
$10.05M
10-Q · filed 2012-05-11
2011-12-31$557.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29
$1.21M
derived: sum of 2 quarters · filed 2013-03-29
$2.53M
derived: sum of 3 quarters · filed 2013-03-29
$3.25M
10-K · filed 2013-03-29
$9.58M
10-K · filed 2012-03-30
2011-09-30$649.00K
10-Q · filed 2012-11-09
$1.98M
derived: sum of 2 quarters · filed 2012-11-09
$2.69M
10-Q · filed 2012-11-09
$3.06M
derived: sum of 4 quarters · filed 2012-11-09
$9.03M
10-Q · filed 2011-11-10
2011-06-30$1.33M
10-Q · filed 2012-08-10
$2.04M
10-Q · filed 2012-08-10
$2.41M
derived: sum of 3 quarters · filed 2012-08-10
$2.81M
derived: sum of 4 quarters · filed 2012-08-10
$8.38M
10-Q · filed 2011-08-12
2011-03-31$711.00K
10-Q · filed 2012-05-11
$1.08M
derived: sum of 2 quarters · filed 2012-05-11
$1.48M
derived: sum of 3 quarters · filed 2012-05-11
2010-12-31$367.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$771.00K
derived: sum of 2 quarters · filed 2012-03-30
$1.94M
10-K · filed 2012-03-30
2010-09-30$404.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
$1.57M
10-Q · filed 2011-11-10
2010-06-30$1.17M
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Rezolute, Inc. (RZLT)United States$0.382B-6.45
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63